{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T02:18:36Z","timestamp":1772763516709,"version":"3.50.1"},"reference-count":34,"publisher":"BMJ","issue":"5","funder":[{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Independent Research Fund Denmark"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"published-print":{"date-parts":[[2018,5]]},"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>The first birth cohorts of women offered human papillomavirus (HPV) vaccination as girls are now entering cervical screening. However, there is no international consensus on how to screen HPV vaccinated women. These women are better protected against cervical cancer and could therefore be offered less intensive screening. Primary HPV testing is more sensitive than cytology, allowing for a longer screening interval. The aim of Trial23 is to investigate if primary HPV testing with cytology triage of HPV positive samples is a reasonable screening scheme for women offered HPV vaccination as girls.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Trial23 is a method study embedded in the existing cervical screening programme in four out of five Danish regions. Without affecting the screening programme, women born in 1994 are randomised to present screening with liquid-based cytology every third year (present programme arm) or present screening plus an HPV test (HPV arm). The study started 1 February 2017 and will run over three screening rounds corresponding to 7\u20138 years.<\/jats:p><\/jats:sec><jats:sec><jats:title>Analyses<\/jats:title><jats:p>The primary endpoint is cervical intraepithelial neoplasia grade 3 or above. The trial is undertaken as a non-inferiority study including intention-to-treat and per-protocol analyses. The potential effect of primary HPV screening with a 6-year interval will be calculated from the observed data.<\/jats:p><\/jats:sec><jats:sec><jats:title>Ethics and dissemination<\/jats:title><jats:p>The study protocol has been submitted to the ethical committee and deemed a method study. All women are screened according to routine guidelines. The study will contribute new evidence on the future screening of HPV vaccinated birth cohorts of women. All results will be published in open-access journal.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration<\/jats:title><jats:p><jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"NCT03049553\" ext-link-type=\"clintrialgov\" specific-use=\"clinicaltrial pre-results\">NCT03049553<\/jats:ext-link>.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bmjopen-2017-020294","type":"journal-article","created":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T17:48:02Z","timestamp":1680716882000},"page":"e020294","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":8,"title":["Danish method study on cervical screening in women offered HPV vaccination as girls (Trial23): a study protocol"],"prefix":"10.1136","volume":"8","clinical-trial-number":[{"clinical-trial-number":"nct03049553","registry":"10.18810\/clinical-trials-gov","type":"preResults"},{"clinical-trial-number":"nct03049553","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Lise Holst","family":"Thamsborg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berit","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lise Grupe","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jette","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tonje","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jalil","family":"Hariri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanne","family":"Christiansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carsten","family":"Rygaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elsebeth","family":"Lynge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2018,5,26]]},"reference":[{"key":"2023040221235560000_8.5.e020294.1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F"},{"key":"2023040221235560000_8.5.e020294.2","unstructured":"EPI-NEWS. Statens Serum Institut [in Danish]. 2008 http:\/\/www.ssi.dk\/~\/media\/Indhold\/EN%20-%20engelsk\/EPI-NEWS\/2008\/pdf\/EPI-NEWS%20-%202008%20-%20No%2035.ashx"},{"key":"2023040221235560000_8.5.e020294.3","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70230-8"},{"key":"2023040221235560000_8.5.e020294.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa061760"},{"key":"2023040221235560000_8.5.e020294.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa061741"},{"key":"2023040221235560000_8.5.e020294.6","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djp534"},{"key":"2023040221235560000_8.5.e020294.7","unstructured":"National recommendations for cervical screening. (Sundhedsstyrelsens anbefalinger) [summary in English]. 2012 http:\/\/www.sst.dk\/~\/media\/B1211EAFEDFB47C5822E883205F99B79.ashx (accessed 20 Dec 2015)."},{"key":"2023040221235560000_8.5.e020294.8","unstructured":"Quality report on the Danish cervical cancer screening program (DKLS \u00e5rsrapport). 2015 https:\/\/www.sundhed.dk\/content\/cms\/82\/4682_dkls-%C3%A5rsrapport-2015.pdf."},{"key":"2023040221235560000_8.5.e020294.9","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.3109\/0284186X.2015.1016625","article-title":"Hysterectomy and its impact on the calculated incidence of cervical cancer and screening coverage in Denmark","volume":"54","author":"Lam","year":"2015","journal-title":"Acta Oncol"},{"key":"2023040221235560000_8.5.e020294.10","doi-asserted-by":"publisher","DOI":"10.1002\/cncy.21643"},{"key":"2023040221235560000_8.5.e020294.11","unstructured":"Swedish recommendations for cervical Screening. 2015 https:\/\/www.socialstyrelsen.se\/riktlinjer\/nationellascreeningprogram\/livmoderhalscancer screeningme (accessed 20 Dec 2015)."},{"key":"2023040221235560000_8.5.e020294.12","unstructured":"National Screening Unit. Planned changes to cervical screening test in 2018. New Zealand, 2018. https:\/\/www.nsu.govt.nz\/news\/planned-changes-cervical-screening-test-2018. (accessed 10 May 2018)."},{"key":"2023040221235560000_8.5.e020294.13","unstructured":"National Institute of Public Health and Environment. Cervical cancer screening in the Netherlands. http:\/\/www.rivm.nl\/en\/Documents_and_publications\/Common_and_Present\/Newsmessages\/2014\/Cervical_cancer_screening_in_the_Netherlands (accessed 10 May 2017)."},{"key":"2023040221235560000_8.5.e020294.14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62218-7"},{"key":"2023040221235560000_8.5.e020294.15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.a1754"},{"key":"2023040221235560000_8.5.e020294.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2011.01.008"},{"key":"2023040221235560000_8.5.e020294.17","unstructured":"European Commission. European guidelines for quality assurance in cervical cancer screening. http:\/\/www.ispo.toscana.it\/sites\/default\/files\/Documenti\/raccomandazioni\/supplemento%202015.pdf (accessed 20 Dec 2015)."},{"key":"2023040221235560000_8.5.e020294.18","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1991.350"},{"key":"2023040221235560000_8.5.e020294.19","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10552-013-0320-z","article-title":"Carcinogenic HPV prevalence and age-specific type distribution in 40,382 women with normal cervical cytology, ASCUS\/LSIL, HSIL, or cervical cancer: what is the potential for prevention?","volume":"25","author":"Kj\u00e6r","year":"2014","journal-title":"Cancer Causes Control"},{"key":"2023040221235560000_8.5.e020294.20","unstructured":"Statens Serum Institut. Vaccine coverage [in Danish]. http:\/\/www.ssi.dk\/Smitteberedskab\/Sygdomsovervaagning\/VaccinationSurveillance.aspx?xaxis=Cohort&vaccination=5&sex=0&landsdel=100&show=&datatype=Vaccination&extendedfilters=True#HeaderText (accessed 10 Jul 2017)."},{"key":"2023040221235560000_8.5.e020294.21","unstructured":"Statens Institut for Folkesundhed. School Survey 2010 (Skoleb\u00f8rnsunders\u00f8gelsen) [in Danish]. http:\/\/www.hbsc.dk\/downcount\/HBSC-Rapport-2010.pdf (accessed 20 Dec 2015)."},{"key":"2023040221235560000_8.5.e020294.22","unstructured":"Statistics Denmark. Population count. http:\/\/www.statistikbanken.dk\/statbank5a\/selectvarval\/define.asp?PLanguage=0&subword=tabsel&MainTable=FOLK1A&PXSId=199113&tablestyle=&ST=SD&buttons=0 (accessed 10 Jul 2017)."},{"key":"2023040221235560000_8.5.e020294.23","unstructured":"Guidelines Danish society of gynecology and obstetrics [in Danish]. http:\/\/gynobsguideline.dk\/hindsgavl\/Cervixdysplasi2012.pdf"},{"key":"2023040221235560000_8.5.e020294.24","unstructured":"Roche Molecular Diagnostics. Cobas HPV-test. https:\/\/molecular.roche.com\/assays\/cobas-hpv-test\/ (accessed 3 Jul 2017)."},{"key":"2023040221235560000_8.5.e020294.25","unstructured":"Roche. PKG INS, CINtec p16 Histology, English. http:\/\/productlibrary.ventana.com\/ventana_portal (accessed 3 Jul 2017)."},{"key":"2023040221235560000_8.5.e020294.26","doi-asserted-by":"crossref","unstructured":"Hestbech MS , Lynge E , Kragstrup J , et al . The impact of HPV vaccination on future cervical screening: a simulation study of two birth cohorts in Denmark. BMJ Open 2015;5:e007921.doi:10.1136\/bmjopen-2015-007921","DOI":"10.1136\/bmjopen-2015-007921"},{"key":"2023040221235560000_8.5.e020294.27","unstructured":"Rigsarkivat. Danish data archive [in Danish]. https:\/\/www.sa.dk\/da\/brug-arkivet\/dda\/ (accessed 6 Oct 2017)."},{"key":"2023040221235560000_8.5.e020294.28","doi-asserted-by":"crossref","unstructured":"Lamin H , Eklund C , Elfstr\u00f6m KM , et al . Randomised healthcare policy evaluation of organised primary human papillomavirus screening of women aged 56-60. BMJ Open 2017;7:e014788.doi:10.1136\/bmjopen-2016-014788","DOI":"10.1136\/bmjopen-2016-014788"},{"key":"2023040221235560000_8.5.e020294.29","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djp367"},{"key":"2023040221235560000_8.5.e020294.30","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ypmed.2016.11.020","article-title":"Cervical cancer screening in women vaccinated against human papillomavirus infection: Recommendations from a consensus conference","volume":"98","author":"Giorgi Rossi","year":"2017","journal-title":"Prev Med"},{"key":"2023040221235560000_8.5.e020294.31","doi-asserted-by":"crossref","unstructured":"M\u00f8lbak K , Hansen ND , Valentiner-Branth P . Pre-vaccination care-seeking in females reporting severe adverse reactions to hpv vaccine. a registry based case-control study. PLoS One 2016;11:e0162520.doi:10.1371\/journal.pone.0162520","DOI":"10.1371\/journal.pone.0162520"},{"key":"2023040221235560000_8.5.e020294.32","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1016\/S0140-6736(15)61152-7","article-title":"HPV vaccination crisis in Japan","volume":"385","author":"Hanley","year":"2015","journal-title":"The Lancet"},{"key":"2023040221235560000_8.5.e020294.33","unstructured":"National Institute for Public Helath and Enviroment. Risk of measles outbreaks increases with decreasing vaccination coverage. The Netherlands, 2017. http:\/\/www.rivm.nl\/en\/Documents_and_publications\/Common_and_Present\/Newsmessages\/2017\/Risk_of_measles_outbreaks_increases_with_decreasing_vaccination_coverage (accessed 3 Jul 2017)."},{"key":"2023040221235560000_8.5.e020294.34","unstructured":"thejournal.ie. News article: Irish parents are stopping their children from getting a cervical cancer vaccine - but why? http:\/\/www.thejournal.ie\/hpv-vaccine-4-2697247-Apr2016\/"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2017-020294","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T17:48:17Z","timestamp":1680716897000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2017-020294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":34,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,5,26]]},"published-print":{"date-parts":[[2018,5]]}},"alternative-id":["10.1136\/bmjopen-2017-020294"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2017-020294","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5]]}}}